Tesamorelin pode ser usado para emagrecer?

A aprovação FDA é especificamente para lipodistrofia associada ao HIV, não para emagrecimento geral. Uso off-label existe, mas não é indicação aprovada. Para obesidade, semaglutida e tirzepatida têm muito mais evidência.

Hormônio de CrescimentoEgrifta

Tesamorelin

GHRH analog approved by the FDA for visceral fat reduction in HIV patients with lipodystrophy. Currently the only GH secretagogue with active FDA approval. Also researched for hepatic steatosis (fatty liver) and cognitive decline.

Last updated:: 06/04/2026

Research Status

Pré-clínicoFase 1Fase 2Fase 3Aprovado

ANVISA (Brazil)

Not regulated

FDA (USA)

Approved

EMA (Europe)

Not regulated

Mechanism of Action

Tesamorelin is a modified GHRH analog with the addition of a trans-3-hexenoic acid at the N-terminal position, increasing its stability and potency. It stimulates physiological GH release from the pituitary, selectively reducing visceral fat without proportionally affecting subcutaneous fat.

Study Protocols

Dosages and regimens used in published clinical studies. This does not constitute a medical prescription.

Lipodistrofia associada ao HIV

Subcutânea (SC)

Protocolo padrão2 mg1x/dia · 26 semanas

Aplicar no abdômen

Aprovado pelo FDA (Egrifta). Análogo do GHRH. Redução significativa de gordura visceral sem alterar gordura subcutânea.

Falutz J et al., NEJM 2007

Benefits

Visceral fat reduction

Proven

FDA-approved (2010). Studies demonstrated a 15-18% reduction in visceral fat (trunk fat) in HIV patients with lipodystrophy.

View study

Hepatic fat reduction

Under research

Studies show significant reduction in liver fat (NAFLD/NASH) in both HIV and non-HIV patients.

View study

Cognitive benefits

Under research

Studies in adults with mild cognitive impairment show improvement in memory and executive function.

Risks and Side Effects

Arthralgias

Low(13% of patients)

Joint pain is the most common side effect. Generally mild to moderate.

Peripheral edema

Low(6% of patients)

Mild swelling in the extremities, related to increased GH/IGF-1.

Internet vs. Science

What people say online compared to the actual scientific evidence.

Melts abdominal fat

Partially true

What they claim

Tesamorelin is the best peptide for eliminating belly fat — FDA-approved for that.

Actual evidence

FDA-approved for visceral fat reduction in HIV lipodystrophy (15-18% reduction). Effective, but approved for a specific population. Off-label use for general abdominal fat is common but is not an approved indication.

Claim	O que dizem	Evidência real	Verdict
Melts abdominal fat	Tesamorelin is the best peptide for eliminating belly fat — FDA-approved for that.	FDA-approved for visceral fat reduction in HIV lipodystrophy (15-18% reduction). Effective, but approved for a specific population. Off-label use for general abdominal fat is common but is not an approved indication.	Partially true

Studies and References (1)

Effects of Tesamorelin on Abdominal Fat in HIV-infected Patients

Falutz J, Allas S, Blot K, et al. — New England Journal of Medicine (2007) — n=412

Randomized Clinical Trial

Tesamorelin reduziu gordura visceral em 15.2% vs aumento de 5% com placebo em 26 semanas em pacientes HIV com lipodistrofia.

PubMed

Frequently Asked Questions

Can tesamorelin be used for weight loss?

FDA approval is specifically for HIV-associated lipodystrophy, not for general weight loss. Off-label use exists but is not an approved indication. For obesity, semaglutide and tirzepatide have much more evidence.

Important notice

This content is strictly informational and educational, based on published scientific research. It does not constitute medical advice, prescription, or encouragement to use any substance. Always consult a qualified physician before starting any treatment.

How to Obtain

This is an approved medication. A medical prescription is required for purchase.

Find a Prescribing Physician